NL-OMON22932招募中不适用
International GBS Outcome Study (IGOS): A prospective INC study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,000
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Criteria for inclusion of patients in the IGOS:
- •1. Fulfil the diagnostic criteria for GBS of the National Institute of Neurological Disorders and Stroke (NINDS). In addition all patients with Miller Fisher syndrome (MFS) and other variants of GBS, including overlap syndromes can be included, for which additional diagnostic criteria will be provided;
排除标准
- •To limit selection bias as much as possible there are no exclusion criteria to be included in IGOS.
研究者
相似试验
招募中
不适用
International GBS Outcome Study A prospective INC study on clinical and biological predictors of disease course en outcome in GBSGuillain-Barré syndrome100038161001981510034606NL-OMON47523Erasmus MC, Universitair Medisch Centrum Rotterdam200
已完成
不适用
International Guillain-Barré Syndrome Outcome StudyGuillain-Barré SyndromeMiller Fisher SyndromeNCT01582763Erasmus Medical Center2,000
暂停
不适用
International Second Immunoglobulin Dose in Guillain-Barré Syndrome patients with poor prognosis.NO LONGER A SEPARATE STUDY. THIS STUDY WILL BELONG TO THE IGOS STUDY (NTR 3290).Guillain-Barré syndromeNL-OMON24041Erasmus Medical Center300
招募中
不适用
Gaucher Disease Outcome Survey (GOS)Gaucher DiseaseNCT03291223Shire1,257
已完成
1 期
A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of AgeInvasive Group B Streptococcus (GBS) DiseaseNCT00645346Novartis Vaccines130